Suivre
Federica Defendi
Federica Defendi
Laboratoire d'Immunologi CHU Grenoble
Adresse e-mail validée de chu-grenoble.fr
Titre
Citée par
Citée par
Année
Enzymatic assays for the diagnosis of bradykinin-dependent angioedema
F Defendi, D Charignon, A Ghannam, R Baroso, F Csopaki, ...
PLoS One 8 (8), e70140, 2013
742013
The immunopathology of complement proteins and innate immunity in autoimmune disease
F Defendi, NM Thielens, G Clavarino, JY Cesbron, C Dumestre-Pérard
Clinical Reviews in Allergy & Immunology 58, 229-251, 2020
592020
Plasminogen gene mutation with normal C1 inhibitor hereditary angioedema: three additional French families
A Belbézier, G Hardy, R Marlu, F Defendi, CD Perard, I Boccon-Gibod, ...
Allergy 73 (11), 2237-2239, 2018
512018
Characterization of superoxide overproduction by the D-LoopNox4-Nox2 cytochrome b558 in phagocytes—Differential sensitivity to calcium and phosphorylation events
L Carrichon, A Picciocchi, F Debeurme, F Defendi, S Beaumel, AJ Jesaitis, ...
Biochimica et Biophysica Acta (BBA)-Biomembranes 1808 (1), 78-90, 2011
472011
Hereditary angioedema with F12 mutation: factors modifying the clinical phenotype
D Charignon, A Ghannam, F Defendi, D Ponard, N Monnier, ...
Allergy 69 (12), 1659-1665, 2014
442014
Complement alternative and mannose-binding lectin pathway activation is associated with COVID-19 mortality
F Defendi, C Leroy, O Epaulard, G Clavarino, A Vilotitch, M Le Marechal, ...
Frontiers in immunology 12, 742446, 2021
342021
Kininogen cleavage assay: diagnostic assistance for kinin-mediated angioedema conditions
R Baroso, P Sellier, F Defendi, D Charignon, A Ghannam, M Habib, ...
PLoS One 11 (9), e0163958, 2016
292016
C1 inhibitor function using contact‐phase proteases as target: evaluation of an innovative assay
A Ghannam, P Sellier, F Defendi, B Favier, D Charignon, A López‐Lera, ...
Allergy 70 (9), 1103-1111, 2015
262015
Iatrogenic angioedema associated with ACEi, sitagliptin, and deficiency of 3 enzymes catabolizing bradykinin
C EUR
242014
A novel point mutation in the CYBB gene promoter leading to a rare X minus chronic granulomatous disease variant—impact on the microbicidal activity of neutrophils
F Defendi, E Decleva, C Martel, P Dri, MJ Stasia
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1792 (3), 201-210, 2009
232009
Effect of double-filtration plasmapheresis for antibody-mediated rejection on hemostasis parameters and thrombin generation
R Marlu, P Malvezzi, L Seyve, T Jouve, J Maurizi, F Defendi, PL Carron, ...
Thrombosis Research 166, 113-121, 2018
172018
Distinct conditions support a novel classification for bradykinin-mediated angio-oedema
P Dessart, F Defendi, H Humeau, B Nicolie, ME Sarre, D Charignon, ...
Dermatology 230 (4), 324-331, 2015
172015
Contact system activation in patients with HAE and normal C1 inhibitor function
A Ghannam, F Defendi, D Charignon, F Csopaki, B Favier, M Habib, ...
Immunology and Allergy Clinics 33 (4), 513-533, 2013
172013
Update on bradykinin-mediated angioedema in 2020
M Lepelley, C Bernardeau, F Defendi, J Crochet, M Mallaret, L Bouillet
Therapies 75 (2), 195-205, 2020
152020
Acquired angioedema due to C1-inhibitor deficiency: CREAK recommendations for diagnosis and treatment
D Gobert, L Bouillet, G Armengol, P Coppo, F Defendi, A Du-Thanh, ...
La Revue de Medecine Interne 41 (12), 838-842, 2020
122020
Diagnostic biologique des angioedemes bradykiniques: les recommandations du CREAK
L Bouillet, F Defendi, G Hardy, JY Cesbron, I Boccon-Gibod, A Deroux, ...
La Presse Médicale 48 (1), 55-62, 2019
112019
Actualités biologiques sur les angioedèmes à kinines
F Defendi, D Charignon, F Csopaki, D Ponard, C Drouet
Revue francophone des Laboratoires 2012 (444), 39-52, 2012
82012
Effects of immunoadsorption combined with membrane filtration on complement markers–results of a randomized, controlled, crossover study
F Defendi, P Malvezzi, F Eskandary, JY Cesbron, L Rostaing, GA Böhmig, ...
Transplant International 32 (8), 876-883, 2019
72019
Fetuin-A and thyroxin binding globulin predict rituximab response in rheumatoid arthritis patients with insufficient response to anti-TNFα
MVC Nguyen, A Courtier, A Adrait, F Defendi, Y Couté, A Baillet, L Guigue, ...
Clinical Rheumatology 39, 2553-2562, 2020
52020
Intracellular shunting of O2− contributes to charge compensation and preservation of neutrophil respiratory burst in the absence of voltage-gated proton channel activity
E Decleva, R Menegazzi, A Fasolo, F Defendi, M Sebastianutto, P Dri
Experimental cell research 319 (12), 1875-1888, 2013
52013
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20